Biotest GmbH & Co. KGaA (HAM:BIO0)
33.20
0.00 (0.00%)
At close: Aug 14, 2026
Biotest GmbH & Co. KGaA Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 648.9 | 648.9 | 726.2 | 684.6 | 516.1 | 515.6 |
Revenue Growth | -16.95% | -10.64% | 6.08% | 32.65% | 0.10% | 6.49% |
Gross Profit Gross Profit Growth | 69.5 | 69.5 | 223.8 | 280.3 | 124.9 | 80.7 |
Operating Income Operating Income Growth | -56.5 | -56.5 | 86.8 | 116.7 | -20.2 | -50.9 |
Net Income Net Income Growth | -70.7 | -70.7 | 26.4 | 127 | -31.7 | -63.4 |
Earnings Per Share EPS Growth | -1.79 | -1.79 | 0.67 | 3.20 | -0.80 | -1.60 |
EPS Growth | - | - | -79.15% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Germany Germany Growth | 600 | 600 | 684.8 | 616.2 | 393.2 |
Rest of World Rest of World Growth | 48.9 | 48.9 | 41.4 | 68.4 | 122.8 |
Total Total Growth | 648.9 | 648.9 | 726.2 | 684.6 | 516 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 89.8 | 89.8 | 107.8 | 118.5 | 129 | 113.1 |
Total Debt Total Debt Growth | 831.6 | 831.6 | 671.8 | 689.8 | 644.1 | 531.2 |
Net Cash (Debt) Net Cash Growth | -741.8 | -741.8 | -564 | -571.3 | -515.1 | -418.1 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -18.75 | -18.75 | -14.25 | -14.44 | -13.02 | -10.57 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -144.9 | -144.9 | 60.9 | -2.7 | -40.5 | 33.8 |
Capital Expenditures CapEx Growth | -11.6 | -11.6 | -28.7 | -33.4 | -29.3 | -18.2 |
Free Cash Flow Free Cash Flow Growth | -156.5 | -156.5 | 32.2 | -36.1 | -69.8 | 15.6 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 10.71% | 10.71% | 30.82% | 40.94% | 24.20% | 15.65% |
Operating Margin | -8.71% | -8.71% | 11.95% | 17.05% | -3.91% | -9.87% |
Pretax Margin | -14.38% | -14.38% | 6.42% | 15.53% | -5.99% | -12.16% |
Profit Margin | -10.90% | -10.90% | 3.64% | 18.55% | -6.14% | -12.30% |
FCF Margin | -24.12% | -24.12% | 4.43% | -5.27% | -13.53% | 3.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.040 | 0.040 | 0.040 | 0.040 | - | 0.040 |
Dividend Per Share Growth | 0% | 0% | 0% | - | - | 0% |
Dividend Yield | 0.12% | 0.13% | - | - | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 18.90 | 24.51 | 51.60 | 51.60 | 51.60 |
PS Ratio | 2.02 | 2.22 | - | - | - | - |